Turnstone Biologics Corp. (TSBX)
NASDAQ:TSBX
US Market
Holding TSBX?
Track your performance easily

Turnstone Biologics Corp. (TSBX) Financial Statements

39 Followers

Turnstone Biologics Corp. Financial Overview

Turnstone Biologics Corp.'s market cap is currently ―. The company's EPS TTM is $-3.259; its P/E ratio is -0.19; Turnstone Biologics Corp. is scheduled to report earnings on November 8, 2024, and the estimated EPS forecast is $-0.89. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Mar 24
Income Statement-
Total Revenue--
Gross Profit--
EBIT$ -21.30M$ -19.61M
EBITDA$ -20.80M$ -19.10M
Net Income Common Stockholders$ -21.30M$ -19.63M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 62.40M$ 77.85M
Total Assets$ 76.88M$ 94.39M
Total Debt$ 2.20M$ 2.72M
Net Debt$ -60.19M$ -75.13M
Total Liabilities$ 17.14M$ 14.38M
Stockholders Equity$ 59.74M$ 80.01M
Cash Flow-
Free Cash Flow$ -16.00M$ -17.60M
Operating Cash Flow$ -15.93M$ -17.46M
Investing Cash Flow$ 18.94M$ 14.10M
Financing Cash Flow$ -48.00K-
Currency in USD

Turnstone Biologics Corp. Earnings and Revenue History

Turnstone Biologics Corp. Debt to Assets

Turnstone Biologics Corp. Cash Flow

Turnstone Biologics Corp. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis